ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:EXK • CA29258Y1034

11.88 USD
+0.27 (+2.33%)
At close: Feb 4, 2026
12 USD
+0.12 (+1.01%)
After Hours: 2/4/2026, 8:16:55 PM
Fundamental Rating

3

Overall EXK gets a fundamental rating of 3 out of 10. We evaluated EXK against 157 industry peers in the Metals & Mining industry. Both the profitability and financial health of EXK have multiple concerns. EXK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • EXK had negative earnings in the past year.
  • In the past year EXK had a positive cash flow from operations.
  • Of the past 5 years EXK 4 years were profitable.
  • EXK had a positive operating cash flow in each of the past 5 years.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -9.27%, EXK is doing worse than 68.15% of the companies in the same industry.
  • EXK has a Return On Equity of -18.53%. This is in the lower half of the industry: EXK underperforms 68.15% of its industry peers.
  • With a Return On Invested Capital value of 0.08%, EXK perfoms like the industry average, outperforming 47.13% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for EXK is significantly below the industry average of 10.48%.
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROIC 0.08%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • EXK has a Operating Margin of 0.23%. This is comparable to the rest of the industry: EXK outperforms 47.77% of its industry peers.
  • EXK's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 13.03%, EXK is in line with its industry, outperforming 45.22% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 0.23%
PM (TTM) N/A
GM 13.03%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

  • EXK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, EXK has more shares outstanding
  • EXK has more shares outstanding than it did 5 years ago.
  • EXK has a worse debt/assets ratio than last year.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.66 indicates that EXK is not in any danger for bankruptcy at the moment.
  • EXK's Altman-Z score of 3.66 is in line compared to the rest of the industry. EXK outperforms 49.04% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that EXK is not too dependend on debt financing.
  • EXK has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: EXK outperforms 46.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 3.66
ROIC/WACC0.01
WACC9.86%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 0.79 indicates that EXK may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.79, EXK is doing worse than 89.81% of the companies in the same industry.
  • A Quick Ratio of 0.57 indicates that EXK may have some problems paying its short term obligations.
  • The Quick ratio of EXK (0.57) is worse than 86.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.57
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

  • The earnings per share for EXK have decreased strongly by -66.67% in the last year.
  • Looking at the last year, EXK shows a very strong growth in Revenue. The Revenue has grown by 49.22%.
  • The Revenue has been growing by 12.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 61.79% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 39.07% on average over the next years. This is a very strong growth
EPS Next Y112.62%
EPS Next 2Y171.4%
EPS Next 3Y122.15%
EPS Next 5Y61.79%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
  • EXK is valuated quite expensively with a Price/Forward Earnings ratio of 27.68.
  • EXK's Price/Forward Earnings ratio is in line with the industry average.
  • EXK is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 27.68
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

  • EXK's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 64.26
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • EXK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as EXK's earnings are expected to grow with 122.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y171.4%
EPS Next 3Y122.15%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for EXK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ENDEAVOUR SILVER CORP

NYSE:EXK (2/4/2026, 8:16:55 PM)

After market: 12 +0.12 (+1.01%)

11.88

+0.27 (+2.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07
Earnings (Next)02-27
Inst Owners55.15%
Inst Owner Change2.02%
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap3.49B
Revenue(TTM)337.14M
Net Income(TTM)-94.29M
Analysts80
Price Target11.32 (-4.71%)
Short Float %5.66%
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-354.6%
Min EPS beat(2)-595.05%
Max EPS beat(2)-114.14%
EPS beat(4)1
Avg EPS beat(4)-1434.73%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1023.35%
EPS beat(12)2
Avg EPS beat(12)-714.54%
EPS beat(16)3
Avg EPS beat(16)-577.87%
Revenue beat(2)2
Avg Revenue beat(2)8.49%
Min Revenue beat(2)0.04%
Max Revenue beat(2)16.94%
Revenue beat(4)3
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)16.94%
Revenue beat(8)7
Avg Revenue beat(8)2.97%
Revenue beat(12)9
Avg Revenue beat(12)1.92%
Revenue beat(16)10
Avg Revenue beat(16)-0.39%
PT rev (1m)5.53%
PT rev (3m)16.14%
EPS NQ rev (1m)-21.74%
EPS NQ rev (3m)-41.94%
EPS NY rev (1m)111.11%
EPS NY rev (3m)-71.43%
Revenue NQ rev (1m)37.31%
Revenue NQ rev (3m)40.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)10.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.68
P/S 10.37
P/FCF N/A
P/OCF 74.39
P/B 6.87
P/tB 6.87
EV/EBITDA 64.26
EPS(TTM)-0.15
EYN/A
EPS(NY)0.43
Fwd EY3.61%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.16
OCFY1.34%
SpS1.15
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROCE 0.1%
ROIC 0.08%
ROICexc 0.08%
ROICexgc 0.08%
OM 0.23%
PM (TTM) N/A
GM 13.03%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 321.73%
Cap/Sales 52.32%
Interest Coverage 0.06
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.57
Altman-Z 3.66
F-Score3
WACC9.86%
ROIC/WACC0.01
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y112.62%
EPS Next 2Y171.4%
EPS Next 3Y122.15%
EPS Next 5Y61.79%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%
EBIT growth 1Y-91.44%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year123.81%
EBIT Next 3Y140.25%
EBIT Next 5Y60.94%
FCF growth 1Y-134.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.01%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a valuation rating of 3 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Overvalued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the financial health for EXK stock?

The financial health rating of ENDEAVOUR SILVER CORP (EXK) is 2 / 10.


What is the expected EPS growth for ENDEAVOUR SILVER CORP (EXK) stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to grow by 112.62% in the next year.